• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Ind-Swift Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 4123.0
  • ISIN : INE788B01028
16.65 0 (-0.36%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    16.40

  • Today’s High

    17.29

  • Open

    16.70

  • Perv Close

    16.71

  • 52W Low

    12.00

  • 52W High

    34.70

Key Indicators

  • P/E(TTM)

    11.58

  • Mar.Cap (₹Cr.)

    90.18

  • Div & Yield %

    0.00

  • Book Value(₹)

    -74.28

  • Debt-Equity Ratio

    -0.36

  • AGM Date

    01-Aug-2025

  • EPS

    1.44

  • P/E Ratio

    11.58

Financials Ratios

  • Debt-Equity Ratio

    0.00

  • Mar.Cap (₹Cr.)

    90.18

  • RONW (%)

    -12.54

  • ROCE (%)

    3.39

Score Board

  • Equity (₹ in Cr.)

    10.83

  • BV (₹)

    -74.30

  • Sales( ₹ in Cr.)

    515.23

  • NP (in Cr.)

    7.82

  • NP Var(%)

    132.0

  • Div%

    0.0

  • CPS (₹)

    5.80

  • EPS (₹)

    1.40

  • Traded Value (₹ in Lakhs)

    90.35

  • 52 Week High

    34.70

  • 52 Week Low

    12.00

  • Price BSE

    17.0

  • Price NSE

    17.00

  • Market Capital( in Cr.)

    90.35

  • P/C Ratio

    2.90

  • P/E Ratio

    11.80

  • Price Vs.BV

    1.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 502.25 410.96 397.71 356.06 329.52 289.03
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 502.25 410.96 397.71 356.06 329.52 289.03
Other Income 57.99 72.43 24.28 15.22 22.28 34.04
Stock Adjustments -29.85 15.43 1.41 4.46 4.10 -3.12
Total Income 530.39 498.82 423.40 375.74 355.90 319.95
EXPENDITURE :            
Raw Materials 251.33 233.47 212.44 190.99 191.83 156.83
Power and Fuel Cost 12.39 10.96 10.62 9.34 12.40 13.00
Employee Cost 72.92 63.75 57.75 51.17 48.93 46.33
Other Manufacturing Expenses 13.59 13.62 15.08 28.42 22.03 19.51
Selling and Administration Expenses 66.52 61.17 33.72 32.45 32.30 29.13
Miscellaneous Expenses 7.14 1.38 24.17 7.98 2.79 10.36
Employee Benefit Expenses 72.92 63.75 57.75 51.17 48.93 46.33
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 423.89 384.35 353.78 320.36 310.28 275.16
Operating Profit 106.51 114.46 69.63 55.39 45.61 44.79
Interest 62.94 59.76 57.16 52.18 28.68 2.62
Gross Profit 43.57 54.70 12.47 3.21 16.93 42.17
Depreciation 27.11 28.67 32.07 32.70 33.59 33.97
Profit Before Tax 16.46 26.03 -19.60 -29.49 -16.66 8.20
Current Tax 2.23 0.00 0.42 0.32 2.46 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit 14.23 26.04 -20.02 -29.82 -19.12 8.19
Extraordinary Items 38.39 60.82 0.76 -1.20 6.38 26.72
Adjusted Net Profit -24.16 -34.78 -20.78 -28.62 -25.50 -18.53
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -897.47 -923.51 -903.49 -873.67 -854.55 -862.74
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -883.24 -897.47 -923.51 -903.49 -873.67 -854.55
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 2.63 4.81 -3.70 -5.50 -3.53 1.51
Earnings Per Share(Adj)-Unit Curr 2.63 4.81 -3.70 -5.50 -3.53 1.51
Book Value -127.54 -130.10 -132.99 -128.34 -131.66 -124.94
Book Value(Adj)-Unit Curr -127.54 -130.10 -132.99 -128.34 -131.66 -124.94

Shareholding Pattern

  • Promoter Group

    55.58%

  • Public Share Holding

    44.42%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 17,033,433 31.45 17,033,433 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 13,069,910 24.13 13,069,910 20
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 30,103,343 55.58 30,103,343 21
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 509 0.00 509 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 2,000 0.00 2,000 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 2,509 0.00 2,509 3
2] Non Institution
Bodies Corporate 4,798,632 8.86 4,792,132 109
Clearing Members 21,973 0.04 21,973 10
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 866,647 1.60 866,647 120
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 745,001 1.38 745,001 382
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,898,300 5.35 2,898,300 10
Individuals holding nominal share capital up to Rs. 1 lakh 14,208,380 26.23 14,032,278 20,927
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 486,683 0.90 486,683 1
Sub Total 24,058,801 44.42 23,876,199 21,564
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 54,164,653 100.00 53,982,051 21,588

Company Background

Ind-Swift LtdPharmaceuticals - Indian - Formulations

  • Ind-Swift Ltd
  • BSE Code : 4123.0
  • ISIN : INE788B01028

  • Incorporation Year

    1986

  • Registered Office

    781 Industrial Area Phase-II
    Ram Darbar, Chandigarh,
    Chandigarh-160002

  • Telephone

    91-0172-2638781-786

  • FAX

    91-0172-2652242

  • Chairman

    S R Mehta

  • Managing Director

    G Munjal

  • Company Secretary

  • Auditor

    Jain & Associates

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Alankit Assignments Ltd
    Alankit House ,
    4E/2 Jhandewalan Ext,
    Mumbai - New Delhi - 110055

Ind-Swift Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Ind-Swift 16.68 560.24 502.25 0.32 3.39
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10